The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,264.00
Bid: 12,280.00
Ask: 12,282.00
Change: 146.00 (1.20%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,384.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Johnson Set For Brexit Talks With French President

Thu, 22nd Aug 2019 07:50

(Alliance News) - UK Prime Minister Boris Johnson on Thursday is set for showdown Brexit talks in Paris, hours after French President Emmanuel Macron ruled out making concessions.

The UK government was buoyed on Wednesday after comments by German Chancellor Angela Merkel which seemed to indicate that European leaders could be willing to renegotiate the Withdrawal Agreement in a bid to avoid a no-deal Brexit.

Hosting Johnson at the Chancellery in Berlin, Merkel set Britain a 30-day deadline for coming up with an alternative solution to replace the Irish backstop – a bid to avoid a hard border in Northern Ireland after the UK's exit from the EU by keeping Britain aligned with certain regulations set by Brussels.

But Macron told reporters on Wednesday that the demands to renegotiate the Brexit deal were "not an option".

He said: "We have to help the British deal with this internal democratic crisis but we mustn't be hostage to it nor export it."

The frank comments could make Johnson's trip to the Elysee Palace a dicey affair, with the Conservative Party leader set to meet his French counterpart for lunch on Thursday at his official residence to discuss changing the terms of Britain's exit.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called down 0.4% at 7,177.90

----------

Hang Seng: down 0.9% at 26,032.40

Nikkei 225: closed up 0.1% at 20,628.01

DJIA: closed up 0.9% at 26,202.73

S&P 500: closed up 0.8% at 2,924.43

----------

GBP: down at USD1.2113 (USD1.2131)

EUR: down at USD1.1076 (USD1.1097)

Gold: down at USD1,501.56 per ounce (USD1,503.01)

Oil (Brent): firm at USD60.14 a barrel (USD60.75)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

US Fed's Jackson Hole economic policy symposium opens

1100 BST UK CBI Distributive Trades Survey

1100 BST Ireland WPI

0830 CEST Switzerland Industrial Production

0845 CEST France New home sales

0915 CEST France Flash PMI

0930 CEST Germany Flash PMI

1000 CEST Eurozone Flash PMI

1330 CEST ECB accounts from last monetary policy meeting

1600 CEST EU FCCI Flash Consumer Confidence Indicator

0830 EDT Canada Wholesale trade

0830 EDT Canada Employment Insurance

0830 EDT US Unemployment Insurance Weekly Claims Report - Initial Claims

0945 EDT US US Flash Manufacturing PMI

0945 EDT US US Flash Services PMI

1030 EDT US EIA Weekly Natural Gas Storage Report

----------

US Federal Reserve will remain flexible and interest rates will not be on a "preset course" despite persistent risks from trade uncertainty and weak global growth, the central bank said Wednesday. Although the minutes of the Fed's policy meeting late last month showed officials were primarily focused on the risks to the US economy, amid fears about the blowback from President Donald Trump's trade war with Beijing, they stressed that they would keep their options open on their next steps. While they made no mention of Trump's constant attacks on Fed Chairman Jerome Powell, officials said they would be "guided by incoming information and its implications for the economic outlook" and avoid "any appearance of following a preset course," according to the minutes of the Fed's July 30-31 policy meeting. The July rate cut was viewed as "part of a recalibration... or mid-cycle adjustment" and, given the uncertainty surrounding the outlook, the officials "highlighted the need for policymakers to remain flexible and focused on the implications of incoming data for the outlook." However, the minutes showed the central bankers are not unified, with several opposed to cutting rates while a couple favored a bigger cut.

----------

A hard border on the island of Ireland would make a US-UK trade deal "highly unlikely", the UK prime minister has been warned. The Congressional Friends of Ireland, a group in the US Congress which supports and promotes peace and reconciliation in Northern Ireland, has written to Boris Johnson warning that it will oppose any US-UK trade deal if it risks undermining the Good Friday Agreement. According to the letter: "The US, and the more than 33 million Americans with Irish ancestry, share a genuine interest in the continued success of the Good Friday Agreement and the hard-won peace and prosperity it has brought to so many. That is why we strongly oppose any unravelling of the historic treaty or a return of a physical border on the island of Ireland under any circumstances. "We will oppose any US-UK trade deal if the Good Friday Agreement is undermined."

----------

US trade policies, including the trade war with China, will shrink US economic output by 0.3 percentage points by 2020, the US Congressional Budget Office said Wednesday. The report by the non-partisan government agency contradicts President Donald Trump's claims that the tariffs imposed on Chinese goods and Chinese retaliatory tariffs are not harming the US economy. "Tariffs reduce domestic GDP mostly by raising domestic prices, thereby reducing the purchasing power of consumers and increasing the cost of business investment," CBO Director Phillip Swagel said in a statement. US GDP growth is projected to slow from 2.5% in 2018 to 2.3% in 2019. Earlier this month, Trump unexpectedly postponed additional punitive tariffs on Chinese imports to December, anticipating adverse effects on consumer shopping ahead of the Christmas holiday.

----------

BROKER RATING CHANGES

----------

LIBERUM CUTS ANGLO AMERICAN TO 'SELL' ('HOLD') - TARGET 1500 (2200) PENCE

LIBERUM CUTS RIO TINTO TO 'SELL' ('HOLD') - TARGET 3300 (4500) PENCE

LIBERUM CUTS BHP GROUP TO 'SELL' ('HOLD') - TARGET 1400 (2000) PENCE

----------

COMPANIES - FTSE 100

----------

Building materials firm CRH reported interim profit growth and expanded its share buyback programme. Revenue for the first half of 2019 came in at EUR13.22 billion, up from EUR11.94 billion a year ago. Pretax profit rose to EUR707 million from EUR497 million. "On the back of our strategic initiatives, CRH has delivered significant profit growth in the first half of 2019, with a good performance in our heritage business and strong contributions from recent acquisitions," said Chief Executive Albert Manifold. He added: "We are pleased to report that the board plans to continue our share buyback programme with a further tranche of EUR350 million to be completed by year end. This will bring our total share repurchases in 2019 to EUR900 million."

----------

AstraZeneca said roxadustat has been approved in China for the treatment of anaemia in non-dialysis-dependent patients with chronic kidney disease. AstraZeneca and FibroGen China are collaborating on the development and commercialisation of roxadustat in China. FibroGen China, based in Beijing, is a wholly-owned subsidiary of FibroGen Inc.

----------

UAE-focused private healthcare firm NMC Health backed its annual guidance after a solid first half. Revenue for the first half of 2019 rose to USD1.24 billion from USD932.0 million, with pretax profit rising to USD140.6 million from USD118.7 million. NMC said it continues to view the future "with confidence" and reiterated its annual guidance. Separately, the company also said it intends to launch a USD200 million share buyback programme.

----------

COMPANIES - FTSE 250

----------

Animal genetics firm Genus said Finance Director Stephen Wilson has been promoted to the role of chief executive, with effect from "the close of business" on September 13. Current CEO Karim Bitar in March said he would be stepping down to head up ConvaTec. Wilson's finance responsibilities will be undertaken by Janet Duane, currently financial controller on an interim basis. A search for a permanent replacement finance director has already commenced.

----------

Gaming firm Playtech set out share buyback plans despite posting a fall in profit. Revenue for the six months to June 30 was EUR736.1 million, versus just EUR436.5 million a year ago. Pretax profit, however, fell to EUR28.0 million from EUR124.2 million after the firm booked EUR108.6 million in depreciation and amortisation charges, versus just EUR60.6 million a year ago. In addition, Playtech recognised a EUR87.4 million fair value gain on equity investments in the year ago period, which fell to just EUR141,000 in the first half of 2019. Playtech halved its interim dividend to 6.1 euro cents from 12.1 cents a year ago but, including a planned EUR25 million buyback, total shareholder returns were up 15% year-on-year for the half.

----------

COMPANIES - OTHER MAIN MARKET AND AIM

----------

Ryanair has lost a High Court bid to block strike action by its UK pilots – hours after winning a similar legal move in Dublin. A judge sitting in London on Wednesday rejected an urgent application by the airline for an injunction against the British Airline Pilots' Association. The decision by Justice Lambert came after Ryanair succeeded at the High Court in Dublin earlier on Wednesday in its bid to prevent pilots based in Ireland from going on a 48-hour strike from midnight on Thursday. The airline sought an urgent injunction from the judge in London just hours before the start of threatened industrial action by members of Balpa in a dispute over pay and conditions. After hearing submissions from Ryanair and Balpa, the judge dismissed the various grounds raised by the airline. Strike action by UK Ryanair pilots is due to take place on Thursday and Friday, with a second round of dates in September.

----------

Thursday's Shareholder Meetings

D4T4 Solutions

Castings

----------

London Briefing is available to subscribers as an email newsletter. Contact info@alliancenews.com

More News
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.